|
|
||||||||
1 Department of Molecular and Cellular Biochemistry and Center for Structural Biology, University of Kentucky, Lexington, Kentucky 40536, USA
Reprint requests to: David W. Rodgers, Department of Molecular and Cellular Biochemistry, University of Kentucky, 800 Rose Street, Lexington, KY 40536, USA; e-mail: rodgers{at}focus.gws.uky.edu; fax: (859) 323-1037.
(RECEIVED May 21, 2002; ACCEPTED June 21, 2002)
Article and publication are at http://www.proteinscience.org/cgi/doi/10.1110/ps.0216302.
| Abstract |
|---|
|
|
|---|
Keywords: Thimet oligopeptidase; neurolysin; specificity; substrate; model
| Introduction |
|---|
|
|
|---|
60% sequence identity. They are widely distributed in various tissues, including the central nervous system, and appear to be present in different subcellular compartments in different cell types (Vincent et al. 1996; Kato et al. 1997; Vincent et al. 1997a; Crack et al. 1999; Ferro et al. 1999; Garrido et al. 1999; Oliveira et al. 2000). Both peptidases are known to hydrolyze in vitro various bioactive peptides, including neuropeptides (Dahms and Mentlein 1992; Dando et al. 1993; Barrett et al. 1995), and numerous reports have linked the enzymes to the metabolism of these peptides in vivo (Molineaux et al. 1988; Molineaux and Ayala 1990; Dahms and Mentlein 1992; Da Silva et al. 1992; Barelli et al. 1994; Mentlein and Dahms 1994; Vincent et al. 1995, 1997b). They are therefore frequently classified as neuropeptidases, although they undoubtedly also perform other functions. For example, TOP is thought to hydrolyze peptides that are resistant to degradation by other cytosolic peptidases, reducing the pool of peptides available for antigen presentation (Saric et al. 2001). Both neurolysin and TOP have complex patterns of substrate specificity (Dahms and Mentlein 1992; Dando et al. 1993; Barrett et al. 1995). They cleave at only one or a small number of sites on bioactive peptides, but the recognized cleavage sequences vary widely, with no consistent amino acid preferences at any position relative to the site of hydrolysis. The only common feature of substrates is the prevalence of basic residues, prolines, and glycines. On many peptides, the two enzymes cleave at the same peptide bond, but on a few peptides, they cleave at different positions. The subtle specificity differences between enzymes that metabolize bioactive peptides play a critical role in determining the levels and temporal patterns of these signaling molecules in different tissues and neural circuits. Thimet oligopeptidase and neurolysin are good model systems for investigating the basis for substrate specificity in this class of enzymes.
Recently, we determined the crystal structure of neurolysin at 2.3-Å resolution (Brown et al. 2001). The enzyme (Fig. 1
) has a deep, narrow channel that runs the length of the molecule, and the active site is located about midway along the floor of this channel. Given the high degree of sequence identity with neurolysin, we expect TOP to adopt a nearly identical three-dimensional structure. Neither neurolysin nor TOP is active on peptides >17 residues in length, and the extensive shielding of the active sites provides a basis for this restriction. Modeling of the neuropeptide neurotensin into the channel (Fig. 1
) indicated that the length restriction might be primarily on the sequence N-terminal to the cleavage site and indicated the regions likely to interact with substrate.
|
| Results |
|---|
|
|
|---|
|
|
The sides of the channel have even fewer changes that map to the surface. On the wall opposite the active site residues (Fig. 3c
, left panel), there are only a total of six changes in three different patches. One patch relatively near the active site contains three altered positions, with one, L338/M337, conserved across species. The other wall has five changes in three patches (Fig. 3c
, right panel). The patch from positions E355/N354 and S454/T453 and the patch from I77/T76 and T81/N80 might interact with a substrate peptide five or six residues (C- and N-terminal, respectively) from the cleavage site. The isolated change N424/G423 is quite high on the wall over the active site, and it seems unlikely to play a role in contacting substrate bound in a catalytically competent position.
Because substrate peptide is expected to extend largely along the channel floor and the lower portion of one wall (see Fig. 1b
), the extensive sequence conservation on both channel walls is puzzling. One possibility is that the walls are involved in guiding substrate to the floor of the deep, narrow channel. We therefore computed the surface potential for the walls and found that both surfaces are negatively charged (Fig. 4
), with the wall containing active site residues carrying the stronger potential. Because substrate peptides tend to be basic, it is possible that some of the sequence conservation on the channel walls results from their functioning to steer the peptide into the channel.
|
|
Altering the registration to that found in TOP (Fig. 5a
) shifts some of the positive electrostatic potential on the peptide away from His495 and Arg498. Indeed, this registration places the acidic glutamate, now at P5, in a position to interact with His495. Also, the leucine at P7 might contact Met490, and the arginine at P1` could potentially contact Glu469. Based on this analysis, changes in the residues likely to contact bound neurotensin are consistent with the differences in the peptide bonds targeted by TOP and neurolysin.
A similar analysis can be used to rationalize the different cleavage positions in two synthetic peptides (Fig. 5a
). In both cases, the hydrolyzed peptide bond shifts one position toward the N terminus of the substrate in TOP relative to neurolysin. This change moves an arginine away from Arg498 of TOP and places positively charged residues in what appear to be favorable positions (see below) at P1` or P3` (or both positions). Here they might interact with Glu469. Changes between the two enzymes at residues 491/490 and 496/495 are unlikely to favor one cleavage site over the other, and these residues probably do not play a large role in altering specificity with these peptides.
Juliano and coworkers (Oliveira et al. 2001) have determined neurolysin and TOP kinetic parameters for every possible amino acid substitution (except glycine) at each individual position in the fluorogenic substrate Abz-Gly-Phe-Ser-Pro-
-Phe-Arg-Gln-EDDnp. Differences in Km values, the parameter most easily related to possible changes in binding interactions, can also be at least partially rationalized by sequence variations in the active site channel (Fig. 5b
). On the C-terminal side of the scissile bond, the clear preference of neurolysin for aspartate at P2` is consistent with an interaction with Arg470. In TOP, on the other hand, there is no strong preference at this position. Instead, positively charged residues are preferred at P1` and P3` and are among the most favored residues at P2`, possibly reflecting interactions with Glu469. Contrary to expectations, arginine is clearly preferred by neurolysin at P1`, despite the close proximity of Arg470. In this case, other interactions must determine the preference for a positively charged residue.
N-terminal to the cleavage site, the preference of neurolysin for positively charged residues at P4 and its ability to accommodate arginine at P1 might reflect the relative absence of positive charge on the binding surface. TOP does not prefer positively charged residues at any position, consistent with the change to positively charged residues at positions 495 and 498 in the enzyme. The strong preference of TOP for acidic residues at P3 also may reflect the presence of the two positively charged enzyme residues, which are close enough to interact directly with substrate residue P3. Other preference differences, particularly at positions P1 and P2, are more difficult to rationalize, and visualization by structure determination will likely be necessary to understand them. Overall, though, many of the preference differences at individual positions can be rationalized by considering the relatively small number of sequence differences discussed here.
Modification sites
TOP is activated by low concentrations of reducing agents such as dithiothreitol or mercaptoethanol, and thiol-modifying reagents including iodoacetate and N-ethylmaleimide inhibit both TOP and neurolysin (Tisljar 1993; Serizawa et al. 1995; Shrimpton et al. 1997). Recently, activation was shown to result from reductant-induced dissociation of disulfide-linked inactive multimers of the enzyme (Shrimpton et al. 1997). The multimers lose affinity for a competitive inhibitor of TOP and therefore appear unable to bind substrate. Shrimpton et al. (1997) propose that multimerization blocks access to the TOP active site and indicate that this is a physiological mechanism by which the redox characteristics of the environment regulate the activity of the enzyme.
To assess this model of inactivation by multimerization, we mapped (Fig. 6a
) the positions of the three cysteine residues in TOP thought to mediate intermolecular disulfide bond formation (Shrimpton et al. 1997) onto the surface of neurolysin. These residues are all located within
10 Å of each other on the outer surface of one channel wall. Because no other surface cysteines appear to be involved in multimerization (Shrimpton et al. 1997), disulfide bond formation must place equivalent patches of cysteines from monomers together. The positions of the patches on the outer surface of one channel wall, however, make it unlikely that linked molecules would directly restrict access to their substrate-binding channels. It seems, therefore, that the loss of substrate affinity must result not from simple steric restriction but rather from either an induced conformational change or the inability of TOP multimers to accommodate a conformational change associated with substrate binding.
|
, indicating that any sizable addition to its side-chain would probably clash with bound substrate.
The activity of rat TOP is also modulated by protein kinase A phosphorylation at Ser 644 (Tullai et al. 2000). This modification affects activity on at least one substrate peptide, increasing both Km and kcat by sevenfold, and phosphorylation at this site was shown to occur in rat PC12 and mouse AtT-20 cells. The equivalent residue in neurolysin, Leu 645 (Fig. 2
), occurs in a helix on the surface opposite the floor of the active site channel (Fig. 6c
). In this position, it is
20 Å from the active site zinc, with no obvious connection to any possible substrate-binding surfaces.
| Discussion |
|---|
|
|
|---|
A somewhat surprising result is the high degree of sequence conservation on both walls of the channel, even in regions far away from the active site. These surfaces carry overall negative electrostatic potential in neurolysin, and it is reasonable to suppose that substrate access to the narrow deep channel is assisted by electrostatic steering (Adam and Delbrück 1968; Chou and Zhou 1982). It is also possible that the substrate may not always adopt the extended conformation assumed in the model of neurotensin binding. Somatostatin (Brazeau et al. 1973), for example, is a 14-residue peptide cleaved by both enzymes at multiple sites (Dahms and Mentlein 1992), despite the presence of an internal disulfide bond that prevents an extended conformation. Jacchieri and coworkers (1998) have also suggested that in some peptides, TOP hydrolysis sites may correspond to positions of ß turns. Peptides that bind with a folded conformation would necessarily interact with residues higher on the channel walls than would an extended peptide bound at the floor of the channel. Conservation of channel wall residues then may maintain activity on those peptide substrates that adopt a hairpin or folded conformation.
TOP and neurolysin share the ability to cleave specifically at a variety of sequences that have no identifiable discerning features. The channel of neurolysin is lined with extended loop segments that may alter conformation to accommodate a range of substrate sequences (Brown et al. 2001). One loop (residues 600612) adjacent to the active site is known from the crystal structure to be disordered in the absence of bound substrate peptide. In unpublished work (C.S. Hines, K. Ray, and D.W. Rodgers), we have established that altering a tyrosine residue at the tip of this loop in neurolysin differentially affects recognition of target sequences, showing that this loop is important in recognizing at least some substrates. The loop contains five glycine residues in neurolysin, but one glycine (Gly608) is changed to alanine (Ala607) in TOP. This change to alanine may alter the conformational flexibility of the loop and thereby affect target site recognition. Thus, sequence changes may have more effects than the direct interactions with substrate considered here, particularly given the potential importance of plasticity in the substrate-binding site.
The locations of the three clustered cysteine residues in TOP thought to be involved in multimerization (Shrimpton et al. 1997) indicate that some effect other than simply blocking the substrate-binding channel is involved in inactivation. The residues map to the external face of one channel wall, well removed from any possible direct interactions with bound substrate. Contacts with another molecule in this area might, however, affect the positions of two large helices (
9 and
10 in neurolysin). These helices in turn interact with the open coil region starting at residue 584 in neurolysin, which includes the disordered loop (residues 600612) discussed above. Residues in this open coil region are positioned to interact with substrate peptides, indicating a possible mechanism for transmitting multimerization effects into the substrate-binding site. It is interesting to note that there is an intermolecular contact near this region in crystals of neurolysin, and it has not been possible to soak in substrate analogs without damaging the crystals (C.S. Hines, K. Ray, and D.W. Rodgers, unpubl.). It may be then that contacts here inhibit a conformational change necessary for substrate binding. One puzzling feature of multimerization is the apparent formation of trimers, tetramers, and even higher order aggregates (Shrimpton et al. 1997). The tight clustering of the three implicated cysteines makes it difficult to imagine how more than two molecules could link via these residues.
Finally, the location of the shown phosphorylation site (Tullai et al. 2000) is also somewhat puzzling, because it is positioned on the outside surface of the enzyme, well removed from the active site region. The presence of a negatively charged group below the substrate-binding site might increase the electrostatic interaction with the frequently basic peptide substrates, but the measurements actually show a substantial increase in Km for the only substrate strongly affected (Tullai et al. 2000). That phosphorylation of the enzyme induced only small variations in Km and kcat for the three other substrates tested indicates that the effect of phosphorylation may be specific for certain substrates. It may be that particular conformations of the enzyme required for binding these peptides are inhibited by phosphorylation.
Further analysis of substrate recognition in TOP and neurolysin will be greatly assisted by structures of the enzymes with bound peptide analogs of different sequences. Attempts to determine structures of these complexes are ongoing.
| Materials and methods |
|---|
|
|
|---|
To assess our assumption that the backbone structure of TOP will be nearly identical to that of neurolysin, we submitted the TOP amino acid sequence to the SWISS-MODEL comparative protein-modeling server (Peitsch 1996), which produced a TOP model based on the neurolysin structure. After energy minimization the root mean square deviation on all backbone atoms is only 0.1 Å, with no changes in secondary structure assignments. We then used two protein structure verification methods that characterize the environments of residues to assess the TOP model relative to the known neurolysin structure. Both the PROFILE3D (Luethy et al. 1992) and ERRAT (Colovos and Yeates 1993) programs give comparable scoring for the TOP model and neurolysin, with only 2% or 3% of the residues respectively rejected at the 95% confidence level in ERRAT, for example. Thus, using the neurolysin backbone does not result in TOP residues being placed in incompatible environments. Given the high degrees of sequence identity and similarity, the assumption that the backbone structures are nearly identical is valid for the purposes of the analysis presented here.
| Acknowledgments |
|---|
The publication costs of this article were defrayed in part by payment of page charges. This article must therefore be hereby marked "advertisement" in accordance with 18 USC section 1734 solely to indicate this fact.
| References |
|---|
|
|
|---|
Achstetter, T., Ehmann, C., and Wolf, D.H. 1985. Proteinase yscD: Purification and characterization of a new yeast peptidase. J. Biol. Chem. 260: 45854590.
Adam, G., and Delbrück, M. 1968. Reduction of dimensionality in biological diffusion processes. In Structural chemistry and molecular biology. (eds. A. Rich and N. Davidson) pp. 198207. Freeman, San Francisco.
Barelli, H., Fox-Threlkeld, J.E.T., Dive, V., Daniel, E.E., Vincent, J.P., and Checler, F. 1994. Role of endopeptidase 3.4.24.16 in the catabolism of neurotensin, in vivo, in the vascularly perfused dog ileum. Br. J. Pharmacol. 112: 127132.[Medline]
Barrett, A.J., Brown, M.A., Dando, P.M., Knight, C.G., McKie, N., Rawlings, N.D., and Serizawa, A. 1995. Thimet oligopeptidase and oligopeptidase M or neurolysin. Meth. Enzymol. 248: 529556.[Medline]
Brazeau, P., Vale, W., Burgus, R., Ling, N., Butcher, M., Rivier, J., and Guillemin, R. 1973. Hypothalamic polypeptide that inhibits the secretion of immunoreactive pituitary growth hormone. Science 179: 7779.
Brown, C.K., Madauss, K., Lian, W., Beck, M.R., Tolbert, W.D., and Rodgers, D.W. 2001. Structure of neurolysin reveals a deep channel that limits substrate access. Proc. Natl. Acad. Sci. 98: 31273132.
Carson, M. 1987. Ribbon models of macromolecules. J. Mol. Graphics 5: 103106.
Chou, K. and Zhou, G. 1982. Role of protein outside the active site on the diffusion-controlled reaction of an enzyme. J Am. Chem. Soc. 104: 14091414.[CrossRef]
Colovos, C. and Yeates, T.O. 1993. Verification of protein structures: patterns of nonbonded atomic interactions. Protein Sci. 2: 15111519.[Abstract]
Crack, P.J., Wu, T.J., Cummins, P.M., Ferro, E.S., Tullai, J.W., Glucksman, M.J., and Roberts, J.L. 1999. The association of metalloendopeptidase EC 3.4.24.15 at the extracellular surface of the AtT-20 cell plasma membrane. Brain Res. 835: 113124.[CrossRef][Medline]
Dahms, P. and Mentlein, R. 1992. Purification of the main somatostatin-degrading proteases from rat and pig brains, their action on other neuropeptides, and their identification as endopeptidases 24.15 and 24.16. Eur. J. Biochem. 208: 145154.[Medline]
Dando, P.M., Brown, M.A., and Barrett, A.J. 1993. Human thimet oligopeptidase. Biochem. J. 294: 451457.
Da Silva, A., Dhuy, J., Waeldele, F., Bertrand, C., and Landry, Y. 1992. Endopeptidase 24.15 modulates bradykinin-induced contraction in guinea pig trachae. Eur. J. Pharmacol. 212: 9799.[CrossRef][Medline]
Ferro, E.S., Tullai, J.W., Glucksman, M.J., and Roberts, J.L. 1999. Secretion of metalloendopeptidase 24.15 (EC 3.4.24.15). DNA Cell Biol. 18: 781789.[CrossRef][Medline]
Garrido, P.A., Vandenbulcke, F., Ramjaun, A.R., Vincent, B., Checler, F., Ferro, E., and Beaudet, A. 1999. Confocal microscopy reveals thimet oligopeptidase (EC 3.4.24.15) and neurolysin (EC 3.4.24.16) in the classical secretory pathway. DNA Cell Biol. 18: 323331.[CrossRef][Medline]
Jacchieri, S.G., Gomes, M.D., Juliano, L., and Carmago, A.C.M. 1998. A comparative conformational analysis of thimet oligopeptidase (EC 3.4.24.15) substrates. J. Pept. Res. 51: 452459.[Medline]
Jones, T.A., Zou, J.Y., Cowan, S.W., and Kjeldgaard, M. 1991. Improved methods for building protein models in electron density maps and the location of errors in these models. Acta Crystallogr. A 47: 110119.
Kato, A., Sugiura, N., Saruta, Y., Hosoiri, T., Yasue, H., and Hirose, S. 1997. Targeting of endopeptidase 24.16 to different subcellular compartments by alternative promoter usage. J. Biol. Chem. 272: 1531315322.
Kraulis, P. 1991. MOLSCRIPT: A program to produce both detailed and schematic plots of protein structure. J. Appl. Crystallogr. 24: 946950.[CrossRef]
Luethy, R., Bowie, J.U., and Eisenberg, D. 1992. Assessment of protein models with three-dimensional profiles. Nature 356: 8385.[CrossRef][Medline]
Matthews, B.W., Weaver, L.H., and Kester, W.R. 1974. The conformation of thermolysin. J. Biol. Chem. 249: 80308044.
Mentlein, R. and Dahms, P. 1994. Endopeptidases 24.16 and 24.15 are responsible for the degradation of somatostatin, neurotensin, and other neuropeptides by cultivated rat cortical astrocytes. J. Neurochem. 64: 2737.
Molineaux, C.J. and Ayala, J.M. 1990. An inhibitor of endopeptidase 24.15 blocks the degradation of intraventricularly administered dynorphins. J. Neurochem. 55: 611618.[CrossRef][Medline]
Molineaux, C.J., Lasdun, A., Michaud, C., and Orlowski, M. 1988. Endopeptidase 24.15 is the primary enzyme that degrades luteinizing hormone releasing hormone. J. Neurochem. 51: 624633.[CrossRef][Medline]
Oliveira, V., Ferro, E.S., Gomes, M.D., Oshiro, M.E., Almeida, P.C., Juliano, M.A., and Juliano, L. 2000. Characterization of thiol-, aspartyl-, and thiol-metallo-peptidase activities in Madin-Darby canine kidney cells. J. Cell Biochem. 76: 478488.[CrossRef][Medline]
Oliveira, V., Campos, M., Melo, R.L., Ferro, E.S., Carmago, A.C.M., Juliano, M.A., and Juliano, L. 2001. Substrate specificity characterization of recombinant metallo oligo-peptidases thimet oligopeptidase and neurolysin. Biochemistry 40: 44174425.[CrossRef][Medline]
Peitsch, M.C. 1996. PROMOD and SWISS-MODEL: Internet-based tools for automated comparative protein modeling. Biochem. Soc. Trans. 24: 274279.[Medline]
Rawlings, N.D. and Barrett, A.J. 1995. Evolutionary families of metallopeptidases. Meth. Enzymol. 248: 183228.[Medline]
Saric, T., Beninga, J., Graef, C.I., Akopian, T.N., Rock, K.L., and Goldberg, A.L. 2001. Major histocompatibility complex class Ipresented antigenic peptides are degraded in cytosolic extracts primarily by thimet oligopeptidase. J. Biol. Chem. 276: 3647436481.
Serizawa, A., Dando, P.M., and Barrett, A.J. 1995. Characterization of a mitochondrial metallopeptidase reveals neurolysin as a homolog of thimet oligopeptidase. J. Biol. Chem. 270: 20922098.
Shrimpton, C.N., Glucksman, M.J., Lew, R.A., Tullai, J.W., Margulies, E.H., Roberts, J.L., and Smith, A.I. 1997. Thiol activation of endopeptidase EC 3.4.24.15: A novel mechanism for the regulation of catalytic activity. J. Biol. Chem. 272: 1739517399.
Subramaniam, S. 1998. The Biology Workbench: A seamless database and analysis environment for the biologist. Proteins 32: 12.[CrossRef][Medline]
Thompson, J.D., Higgins, D.G., and Gibson, T.J. 1994. CLUSTAL W: Improving the sensitivity of progressive multiple sequence alignment through sequence weighting, position-specific gap penalties and weight matrix choice. Nucleic Acids Res. 22: 46734680.
Tisljar, U. 1993. Thimet oligopeptidase: A review of a thiol dependent metallo-endopeptidase also known as Pz-peptidase endopeptidase 24.15 and endo-oligopeptidase. Biol. Chem. Hoppe Seyler 374: 91100.[Medline]
Tullai, J.W., Cummins, P.M., Pabon, A., Roberts, J.L., Lopingco, M.C., Shrimpton, C.N., Smith, A.I., Martignetti, J.A., Ferro, E.S., and Glucksman, M.J. 2000. The neuropeptide processing enzyme EC 3.4.24.15 is modulated by protein kinase A phosphorylation. J. Biol. Chem. 275: 3651436522.
Vincent, B., Dive, V., Yiotakis, A., Smadja, C., Maldonado, R., Vincent, J.-P., and Checler, F. 1995. Phosphorous-containing peptides as mixed inhibitors of endopeptidase 3.4.24.15 and 3.4.24.16: Effect on neurotensin degradation in vitro and in vivo. Br. J. Pharmacol. 115: 10531063.[Medline]
Vincent, B., Beaudet, A., Dauch, P., Vincent, J.-P., and Checler, F. 1996. Distinct properties of neuronal and astrocytic endopeptidase 3.4.24.16: A study on differentiation, subcellular distribution, and secretion processes. J. Neuroscience 16: 50495059.
Vincent, B., Dauch, P., Vincent, J.P., and Checler, F. 1997a. Stably transfected human cells overexpressing rat brain endopeptidase 3.4.24.16: Biochemical characterization of the activity and expression of soluble membrane-associated counterparts. J. Neurochem. 68: 837845.[Medline]
Vincent, B., Jiracek, J., Nobel, F., Loog, M., Roques, B., Dive, V., Vincent, J.-P., and Checler, F. 1997b. Effect of a novel selective and potent phosphinic peptide inhibitor of endopeptidase 3.4.24.16 on neurotensin-induced analgesia and neuronal inactivation. Br. J. Pharmacol. 121: 705710.[CrossRef][Medline]
![]()
CiteULike
Connotea
Del.icio.us
Digg
Reddit
Technorati What's this?
This article has been cited by other articles:
![]() |
T. Kadonosono, M. Kato-Murai, and M. Ueda Alteration of substrate specificity of rat neurolysin from matrix metalloproteinase-2/9-type to -3-type specificity by comprehensive mutation Protein Eng. Des. Sel., August 1, 2008; 21(8): 507 - 513. [Abstract] [Full Text] [PDF] |
||||
![]() |
E. J. Lim, S. Sampath, J. Coll-Rodriguez, J. Schmidt, K. Ray, and D. W. Rodgers Swapping the Substrate Specificities of the Neuropeptidases Neurolysin and Thimet Oligopeptidase J. Biol. Chem., March 30, 2007; 282(13): 9722 - 9732. [Abstract] [Full Text] [PDF] |
||||
![]() |
K. Ray, C. S. Hines, J. Coll-Rodriguez, and D. W. Rodgers Crystal Structure of Human Thimet Oligopeptidase Provides Insight into Substrate Recognition, Regulation, and Localization J. Biol. Chem., May 7, 2004; 279(19): 20480 - 20489. [Abstract] [Full Text] [PDF] |
||||
![]() |
J.A. Sigman, M.L. Sharky, S.T. Walsh, A. Pabon, M.J. Glucksman, and A.J. Wolfson Involvement of surface cysteines in activity and multimer formation of thimet oligopeptidase Protein Eng. Des. Sel., August 1, 2003; 16(8): 623 - 628. [Abstract] [Full Text] [PDF] |
||||
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |